Novartis receives FDA approval of Tafinlar + Mekinist for adjuvant treatment of BRAF V600-mutant melanoma Read more
Merck KGaA, Darmstadt, Germany to Develop Abituzumab in Metastatic Colorectal Cancer with SFJ Pharmaceuticals Group Read more
Exelixis and Invenra Enter Into Collaboration to Discover and Develop Novel Biologics to Treat Cancer Read more
Novartis launches FocalView app, providing opportunity for patients to participate in ophthalmology clinical trials from home Read more
AbbVie Submits BLA to FDA for Investigational Treatment Risankizumab for Moderate to Severe Plaque Psoriasis Read more
Concert Pharmaceuticals Completes Enrollment in Phase 2a Trial of CTP-543 in Alopecia Areata Read more
Once-daily Trelegy Ellipta gains expanded indication in the US for the treatment of patients with COPD Read more